What does targeted therapy for prostate cancer mean?
Prostate cancer targeted therapy is a treatment approach that focuses on specific molecular targets associated with prostate cancer. The following is a detailed analysis:
In the development of prostate cancer, certain molecular changes occur, which can serve as therapeutic targets. Targeted therapy works by acting on these specific molecular targets to inhibit or block the growth and spread of cancer cells, thereby achieving therapeutic effects. This type of therapy is typically implemented through medications, including small-molecule targeted drugs or antibody-based drugs. Small-molecule targeted drugs interfere with intracellular signaling pathways in cancer cells, suppressing their growth and division. Antibody drugs, on the other hand, bind to specific molecules on the surface of cancer cells, blocking their proliferation and spread. Key targets in prostate cancer targeted therapy include the androgen receptor, cell proliferation signaling pathways, and angiogenesis. Based on a patient’s individual condition and molecular profile, doctors select appropriate targeted drugs. Compared to conventional chemotherapy and radiotherapy, targeted therapy offers a more precise mechanism of action, enabling more effective suppression of cancer cell growth and spread while minimizing damage to healthy cells.
However, targeted therapy is not suitable for all prostate cancer patients, as molecular profiles may vary among individuals, and some patients may lack actionable targets. For personalized information, it is recommended to consult a qualified physician.